Jonathan Painter
Analyst · Barrington Research
Thanks, Tom. Hello, everyone. It’s my pleasure to brief you on our second quarter results. Overall, we had a good quarter despite the economic challenges that we found in various regions of the globe. Let me begin my remarks with an overview of our financial performance in Q2. We finished the second quarter with revenues of $83 million, which was up slightly compared to same period last year while our gross margins at 44% was just a couple points below the near record margin performance we had in Q2 of last year.
We generated GAAP diluted earnings per share of $0.56 in the second quarter which beat our guidance of $0.52 and was once again one of our better earnings per share performances.
Our EBITDA for the second quarter was $11.4 million or 40% of revenues versus $12.5 million in the second quarter last year. Incidentally, our EBITDA for last 12 months was $46.2 million. Our cash flow from operations was $8.6 million, a 25% increase over Q2 of last year. We also repurchased 325,000 shares of our stock worth $7.3 million during the quarter.
And finally, our cash left debt at the end of the quarter was $30 million. Taking a closer look at our revenue performance in the second quarter, we had a slight increase over Q2 of last year. Revenue increases in our water management product line which benefited from the inclusion of revenues from Kadant endpoint were largely offset by declines in stock prep and food handling.
Excluding FX, revenues were up nearly 5% and all of our major product lines except stock prep saw increases. The decline in stock prep revenues was primarily due to a decrease in capital revenues in China compared to a relatively strong Q2 of last year.
Turning to bookings, we generated $77 million in Q2, down 11% compared to Q2 of 2011 and flat compared to Q1 of this year. Our backlog at the end of Q2 was $94 million, which is down $8 million from the end of Q1, but still quite healthy. The decline in bookings was due primarily to decreases in capital order bookings in Europe and China. Although we continue to see capital project activity in those regions, the general economic conditions have weakened and we do not expect a significant turnaround for the coming months.
Our parts and consumables business on the other hand has remained quite stable. Looking at the bookings in revenue trend chart on Slide 8, you can see our quarterly revenue which is the red line and our bookings which is the blue bars. Revenues were down 1% sequentially and were impacted not only by the weaker economies in Europe and China, but also by the strengthening US dollar. Likewise bookings were flat sequentially in Q2, and has settled in at a rate of just under $80 million per quarter for the last quarters.
Before I leave this slide, I would like to use it to illustrate the difference between the economic prices in 2008 and 2009 and the current global slowdown. As you can see from the quarters in the circle, the 2008-2009 crisis resulted in an extreme decline in bookings and revenue that was completely unprecedented in our history.
Looking at our recent performance, although we have definitely experienced reduced bookings for the last three quarters, we don’t see anything approaching the dramatic and continual decline that we saw in the 2008 and 2009 periods and in addition our aftermarket businesses held up quite well as we'll see in the next slide.
Here again you can see the sharp contrast between our parts and consumables bookings during the 2008 2009 crisis which dropped dramatically and our more recent quarters where the trend is quite stable. Taking a closer look at our parts and consumables performance for Q2, we can see that revenues were up slightly from the relatively healthy parts and consumables revenue of Q2 of 2011, but we are down 3% sequentially.
Overall our revenues for parts and consumables were $84 million and made up 57% of our revenues in the second quarter. Looking at bookings which you saw in the blue bars, you can see the bookings in Q2 declined both sequentially and compared to the same period last year. The sequential decrease of approximately 4% is not unusual as the first quarter is typically our strongest quarter for parts and consumables bookings as mills order parts in anticipation of planned maintenance shutdowns.
Our stock prep parts and consumables bookings in China is a particular bright spot, it is up over 30% in Q2 of last year and up 37% in the first six months of this year. This has been a major focus of ours, because the largest spare parts business in China will help us moderate the more volatile capital business in that region.
I would like to take the next few minutes to provide a brief review of our business activities in each of the major geographic regions of the world, starting with North America.
Despite a somewhat slower second quarter, the paper industry in North America is in fairly good shape and continues to be the strongest market in the world for us. Containerboard in particular showed some strength with operating rates fund at 96% in June and several major producers announcing a $50 per ton price increase to take effect in August.
Tissue showed another strong grade with operating rates remaining in the mid-90s. As a reminder, containerboard and tissue are the most important grades to our business and those two grades along with boxboard make up more than 60% of our customer base.
Our Q2 revenues in North America were $41 million, up 11% compared to the same period last year. This uptick was due in large part to revenue increases in our stock prep and fluid handling product lines.
Bookings in North America were up 3% in Q2 compared to the same period last year. The increase in bookings was led by our fluid handling business which was up more than 20% compared to the same period last year.
One notable order during the quarter was for three scraping doctor systems. Scraping doctors are used in the production of tissue to add bulk and texture to the final product. These doctoring systems are notable for several reasons. First, scraping applications are demanding and our doctors provide our customers higher machine uptime and improved runability.
Secondly because of the nature of the application, scraping doctors require more frequent blade replacement and this can provide us a very nice aftermarket revenue stream going forward.
Taking a look at Europe, Europe’s struggles with its sovereign debt issues continued to impact its economy and the demand for paper products. Containerboard consumption has been flat while the market has been somewhat oversupplied. The weaker Euro should help alleviate the situation at least with regard to inputs from regions outside of Europe.
Our revenues in Europe were down 4% compared to Q2 of last year and 1% sequentially. Bookings in Europe were down 30% in the second quarter compared to a fairly strong Q2 of last year and relatively flat on a sequential basis.
As you can see from the chart, the bookings rate for the last three quarters in Europe seems to have stabilized at around $19 million a quarter. Despite the uncertainty of the region, we do still see a good number of active projects as is the case of North America we booked several large orders for doctoring systems and showers from tissue producers and continue to see good activity in this particular grade.
In addition, we booked two large orders for drying equipments from papermakers in Finland and a major steam system orders from customers in Germany and Italy. With that said the weak economy in Europe and the increasing uncertainty going forward make Europe the area in the world really of most concern to us.
Turning to China, we continue to see relatively weak market conditions as buyers absorb the large amount of capacity that's come online over the last year and the pace of economic growth slows.
Chinese economy grew 7.6% in Q2 of 2012 versus a year earlier, and this is really its slowest pace in three years. Overall [foreign] and domestic consumption has been a drag on Chinese economic growth. We believe the longer term outlook for China and our business is still quite promising.
In addition, there are some indications such as the recent improvement in the manufacturers purchasing index that the government stimulus programs are beginning to have some effect. Our quarterly revenues in China declined 29% in Q2 compared to a strong Q2 in 2011. The decline was due in large part to lower revenues from our stock prep product line, offsetting this revenue decline in our water management and doctoring product lines from relatively strong growth abate from a lower base.
Our bookings in Q2 were down 19% compared to the same period last year, but up 39% sequentially. The decline versus last year was found across all our product lines as you've seen for most of 2012 the financial constraints placed on our customers, as well as softer market demand have contributed to a fairly weak market for capital investment.
That said, as I mentioned earlier our stock prep parts and consumables are increasing quite nicely as we work towards increasing the yield from the large installed base we have of stock prep equipment.
The sequential bookings increased in Q1 was largely due to increased demand from our stock prep and fluid handling product lines, including orders for stock prep system for a coated whiteboard machine and two OCC recycled fiber systems for linerboard machines with a combined value of approximately $6 million.
Our fluid handling business, we picked up a major order for drying equipment for three linerboard machines to be delivered later this year to one of China’s larger paper producers.
Turning to South America, we saw a nice rebound in business in Q2 following the traditional slower summer period in Brazil and Argentina and Chile. Revenues were up 70% in Q2 compared to the same period last year and down 1% sequentially.
Bookings however more than doubled from the previous quarter as we booked a major order for upgrades to two stock prep systems for a major tissue producer with a value of more than $4 million.
We should point out; we have a strong market position in South America for stock prep equipment used in recycled tissue mills. As standards of living improve and the use of tissue products increases in South America, we are well positioned to win new orders for our equipment.
I will conclude my remarks in the various regions we serve with a brief comment on emerging markets and the importance of those markets to our future growth. As shown on the pie chart on Slide 17, revenues for the trailing 12 months coming from emerging economies contributed 40% to our total revenue.
Annual growth in paper production in these markets is projected to grow at nearly 6% through 2016 which is significantly higher than the growth rates forecast for the US and Western Europe.
We have good market positions in many of the areas of the developing world, and we have several initiatives underway designed to capture an increased share of business in these regions. These efforts include establishing more regional sales office, as well as using some of the new communications technology to engage of mill operators in remote regions and as well as leverage our technical and applications expertise.
Once fully implemented, we expect our ability to further penetrate this faster growth markets will be enhanced and the portion of our revenues coming from the emerging markets will make up a larger portion of our total revenues.
I would like to close my remarks with a few comments on our guidance for the full year 2012 in the third quarter. Our biggest concern going forward is the increased economic uncertainty in Europe. In addition, although there are some signs of improvements in the macro economy in China the market for capital spending and the paper industry in China is still relatively weak.
These factors combined with our recent bookings have led us to decrease our guidance for the year. We now expect for the full year to achieve GAAP diluted earnings per share from continuing operations of $2.05 to $2.10 on revenues of $325 million to $330 million which is down from our previous guidance of $2.10 and $2.20 on revenues of $335 million to $345 million.
I should note the FX impact of the stronger dollar reduced our EPS guidance for the second half by $0.03. For the third quarter, we expect to generate $0.49 to $0.51 of diluted earnings per share and revenue of $80 million to $82 million. And I'll now pass the call over to Tom for some additional details on our financial performance.